# US 2009/0275080 A1 · Glucoamylase variants with altered properties

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0275080 A1
- Document ID: US20090275080A1
- Status: Published application
- Kind: A1
- Application number: 12/292,563
- Filed: 2008-11-20
- Published: 2009-11-05
- Earliest claimed: 2007-11-20
- Assignees: Danisco US Inc., Genencor Division
- Inventors: Wolfgang Aehle; Richard R. Bott; Martijn Scheffers; Piet Van Solingen
- Web page: https://patentgrep.com/patent/US20090275080A1

## CPC

- C12N 9/2428: {Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase}
- C12P 7/06: Ethanol, i.e. non-beverage
- C12P 19/02: Monosaccharides (2-ketogulonic acid C12P7/60)
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present disclosure relates to variants of a parent glucoamylase having altered properties (e.g., improved thermostability and/or specific activity). In particular, the present disclosure provides compositions comprising the variant glucoamylases, including starch hydrolyzing compositions and cleaning compositions. The disclosure also relates to DNA constructs encoding the variants and methods of producing the glucoamylase variants in host cells.

## Claims

### Claim 1

A glucoamylase variant comprising two or more amino acid substitutions corresponding to position 61, 73, 417, 430, 431, 503, 511, 535, 539, or 563 of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase, wherein the glucoamylase variant has at least 80% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.

### Claim 2 (depends on 1)

The glucoamylase variant of claim 1, wherein the parent glucoamylase has a catalytic domain that has at least 80% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9, or a starch binding domain that has at least 80% sequence identity with SEQ ID NO: 1 or 2.

### Claim 3 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant has at least 85% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.

### Claim 4 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant has at least 90% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.

### Claim 5 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant has at least 95% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.

### Claim 6 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant has at least 99.5% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.

### Claim 7 (depends on 1)

The glucoamylase variant of claim 1, wherein the parent glucoamylase is SEQ ID NO: 1 or 2.

### Claim 8 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant further comprises one or more amino acid substitutions corresponding to position: 4, 5, 12, 24, 43, 44, 45, 46, 47, 49, 51, 70, 75, 6, 94, 100, 108, 114, 116, 119, 122, 124, 125, 137, 141, 143, 146, 148, 169, 171, 172, 175, 178, 180, 181, 208, 211, 228, 242, 243, 245, 292, 294, 197, 309, 310, 313, 314, 315, 316, 317, 321, 340, 341, 350, 353, 356, 363, 368, 369, 375, 376, 395, 398, 401, 408, 409, 412, 415, 418, 421, 433, 436 or 451 of SEQ ID NO: 2, or an equivalent position in the parent glucoamylase.

### Claim 9 (depends on 1)

The glucoamylase variant of claim 1, wherein the variant further comprises one or more amino acid substitutions corresponding to position: 4, 5, 24, 29, 43, 44, 49, 70, 75, 76, 100, 108, 119, 124, 137, 146, 148, 169, 171, 172, 175, 178, 181, 208, 211, 243, 292, 294, 297, 314, 316, 317, 340, 341, 350, 356, 363, 368, 369, 376, 395, 401, 412, 433, 436 or 451 of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 10 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant further comprises one or more amino acid substitutions corresponding to position: 5, 24, 43, 44, 49, 70, 75, 76, 94, 119, 141, 146, 148, 172, 175, 178, 180, 181, 208, 211, 243, 294, 309, 314, 353, 369, 375, or 409 of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 11 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant further comprises one or more amino acid substitutions corresponding to position: 43, 44, or 294 of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 12 (depends on 1)

The glucoamylase variant of claim 1, wherein the parent glucoamylase is selected from a glucoamylase obtained from a Trichoderma spp., an Aspergillus spp., a Humicola spp., a Penicillium spp., a Talaromyces spp., or a Schizosaccharomyces spp.

### Claim 13 (depends on 12)

The glucoamylase variant of claim 12, wherein the parent glucoamylase is obtained from a Trichoderma spp. or an Aspergillus spp.

### Claim 14 (depends on 1)

The glucoamylase variant of claim 1, wherein the variant comprises two or more amino acid substitutions in a residue corresponding to position: N61I, G73F, L417R/V, T430A/M, A431L/Q, E503A/V, Q511H, A535R, A539R, or N563I/K of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 15 (depends on 14)

The glucoamylase variant of claim 14, wherein the variant further comprises one or more of the following substitutions: D4L/E/R/S/C/A/Q/W, F5C/M/N/R/S/T/V/W, I12L/R, D24E/L/Y/T, F29L/I/D/C/S/V/W, I43F/R/D/Y/S/Q, D44E/H/K/S/N/Y/F/R/C, Y47W, Y49N, Q70R/K/M/P/G/L/F, Q75R/K/A, R76L/M/K/T/P, P94L, D100W/I/Q/M/P/A/N, N119P/T/Y/D/E, N146S/G/C/H/E/D/T/W/L/F/M, Q148V/Y/H/A/C/D/G/M/R/S/T, Y169D/F, Q172C/A/D/R/E/F/H/V/L/M/N/S/T/V, F175H/A/G/R/S/T/C/W/Y, W178A/C/D/E/F/G/H/K/N/R/S/T/V/Y, E180A/C/G/H/I/L/N/P/Q/R/S/T/V/Y/, V181E/C/D/G/H/I/P/T/Y/S/L/K/F/A, Q208L/A/C/E/N/F/H/T, S211C/R/E/A/Y/W/M/H/L/I/R/Q/T, E243 S/R/N/M/Y/A/L, R245A/E/M/I/P/V, I292D/H/P/R/T/N/V/F/L, G294C/D/E/T/Q/I/A, K297F/L/P/T/M/D/N/Q/A/Y/H/S/R/W, R309A/C/G/H/I/N/P/Q/S/T/W/Y/L, Y310E/G/L/P/S/W/R/Q, D313Q, V314A/R/N/D/C/E/Q/G/H/I/L/K/M/F/P/S/T/W/Y, Y315F, Y316Q/R, N317T/H, K340D/T, K341F/D/P/V/G/S, T350S/E/A/N, Q356H/D/E, T363L/R/C/H/W, S368W/D/F/L, S369F, N376Q/T/H/S/V, Y395Q/R/S, A398S/I/T, S401C/v, R408S, N409W/T/K, T412A/H/K/G, R433H/Q, I436A/T, or S451M/T/H of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 16 (depends on 14)

The glucoamylase variant of claim 14, wherein the variant further comprises one or more of the following substitutions: I43F/R/D/Y/S/Q, D44E/H/K/S/N/Y/F/R/C, or G294C/D/E/T/Q/I/A of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase.

### Claim 17 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant exhibits altered thermostability as compared to the parent glucoamylase.

### Claim 18 (depends on 17)

The glucoamylase variant of claim 17, wherein the glucoamylase variant exhibits increased thermostability as compared to the parent glucoamylase.

### Claim 19 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant exhibits altered specific activity as compared to the parent glucoamylase.

### Claim 20 (depends on 19)

The glucoamylase variant of claim 19, wherein the glucoamylase variant exhibits increased specific activity as compared to the parent glucoamylase.

### Claim 21 (depends on 1)

The glucoamylase variant of claim 1, wherein the glucoamylase variant exhibits both increased thermostability and increased specific activity as compared to the parent glucoamylase.

### Claim 22 (depends on 1)

A polynucleotide encoding the variant of claim 1.

### Claim 23 (depends on 22)

A vector comprising the polynucleotide of claim 22.

### Claim 24 (depends on 23)

A host cell comprising the vector of claim 23.

### Claim 25 (depends on 1)

An enzyme composition comprising the glucoamylase variant of claim 1.

### Claim 26 (depends on 25)

The enzyme composition of claim 25 wherein the enzyme composition is used in a starch conversion process.

### Claim 27 (depends on 25)

The enzyme composition of claim 25, wherein the enzyme composition is used in an alcohol fermentation process.

### Claim 28 (depends on 24)

A method of producing a glucoamylase variant in a host cell comprising culturing the host cell of claim 24 under conditions suitable for the expression and production of the glucoamylase variant and producing the glucoamylase variant.

### Claim 29 (depends on 28)

The method according to claim 28 further comprising recovering the glucoamylase variant from the culture.

### Claim 30

A glucoamylase variant comprising amino acid substitutions at residues corresponding to positions: I43Q/D44C, D44C/G294C, I43Q/G294C, or I43Q/D44C/G294 of SEQ ID NO: 2, or an equivalent position in a parent glucoamylase, wherein the glucoamylase variant has at least 80% sequence identity with SEQ ID NO: 1, 2, 3, 5, 6, 7, 8, or 9.
